Luminex (LMNX) Return on Assets ROA from the first quarter of 2021 to first quarter of 2020 and for the year 2021, Average High and Low, Fundamental Ratios from Mar 31 2021 to Mar 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Luminex Corporation  (NASDAQ: LMNX)


Luminex's ROA from the first quarter of 2021 to the first quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Luminex's ROA in the first quarter of 2021?
Luminex Corporation achieved a return on average assets (ROA) of 10.61 % in its first quarter of 2021, this is above LMNX's average return on assets of 5.48%.
Luminex Corporation assets over the 12 months ending in its first quarter of 2021 are valued at $585 million

ROA has improved compared to 6.1% in the fourth quarter of 2020, due to net income growth.

However, within the Healthcare sector 119 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2021 quarter, so far to 828, from total ROA ranking in the fourth quarter of 2020 at 848.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Total Assets Change - 84.52 % 50.49 % 36.19 % -2.13 %
Y / Y Net Income Change 1100 % 61.84 % 1572.78 % 2687.13 % -74.14 %
Net Income (TTM) in million 62 44 42 34 7
Return On Assets (TTM) - 6.1 % 6.64 % 6.06 % 1.28 %
LMNX's Total Ranking # 828 # 848 # 967 # #
Total Assets (TTM) in million 0 788 811 742 532
Seq. Total Assets Change - -2.81 % 9.32 % 39.46 % 24.54 %
Seq. Net Income Change 264.27 % -34.01 % -70.76 % 1607.16 % -50.87 %

LMNX's 5 Years Annual ROA >> Back to LMNX Management Effectiveness >> Compare LMNX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 29
Sector # 120
Overall # 828

Return On Assets Statistics
High Average Low
11.9 %
5.48 %
1.06 %
(Mar 31 2015)   (Sep 30 2019)





Financial Statements
Luminex's Assets $ 0 million LMNX's Balance sheet
Luminex's Income $ 20 million Quarterly LMNX's Income Statement
LMNX's Income by Division See LMNX's Income by Division



Annual Return On Assets (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016
Y / Y Total Assets Change 44.95 % 3.53 % 7.07 % 8.83 % 11.96 %
Total Assets in million 788 544 525 491 451
Y / Y Net Income Change 664.76 % -69.05 % -35.95 % 109.16 % -62.52 %
Net Income in million 44 6 19 29 14
Annual Return On Assets 5.56 % 1.05 % 3.52 % 5.89 % 3.06 %

LMNX's 5 Years Annual ROA >> Back to LMNX Management Effectiveness >> Compare LMNX ROA to its Competitors



Comment on LMNX's ROA in the fiscal year ending 2020
In the fiscal year 2020 ROA improved to 5.56 % compared to prior year, due to annual net income growth of 664.76 % to $43.81 million, while value of Luminex's overall assets grew just by 44.95 % to $788.12 million, compared to $788.12 a year before.


More Return On Assets Ratios
LMNX's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
LMNX's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for LMNX's Competitors
Subscribers only: Roa for Luminex's Suppliers
Subscribers only: Return On Assets for LMNX's Customers

You may also want to know
LMNX's Roi LMNX's Inventory Turnover Ratio LMNX's Growth Rates LMNX's Dividend Comparisons
LMNX's Profitability Ratios LMNX's Asset Turnover Ratio LMNX's Dividend Growth
LMNX's Roe LMNX's Valuation Ratios LMNX's Financial Strength Ratios LMNX's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2021, within Healthcare Sector ROA
Musclepharm Corporation  28.40 %
Adicet Bio Inc   28.24 %
Ironwood Pharmaceuticals inc   27.26 %
Bionexus Gene Lab Corp   26.82 %
Nrc Health  26.50 %
Kronos Bio Inc   25.86 %
Hologic Inc  25.80 %
Viemed Healthcare Inc   25.65 %
Lakeland Industries Inc   25.15 %
Halozyme Therapeutics Inc   25.11 %
Progyny Inc   25.00 %
Regeneron Pharmaceuticals Inc   24.47 %
Neurocrine Biosciences Inc   24.37 %
Vertex Pharmaceuticals Inc  24.34 %
Chemed Corporation  23.70 %
Blueprint Medicines Corporation  22.74 %
Oramed Pharmaceuticals Inc  22.10 %
Integrated Biopharma Inc  21.85 %
Waters Corporation  21.66 %
Pro dex Inc   20.99 %
Infusystem Holdings Inc  20.93 %
Mettler toledo International Inc   20.82 %
Meridian Bioscience Inc   20.63 %
Seagen Inc   20.15 %
Cardiff Lexington Corporation  20.02 %
Elite Health Systems Inc   19.65 %
Elite Pharmaceuticals Inc   19.10 %
Corcept Therapeutics Inc  18.44 %
Lifevantage Corp  17.96 %
Harrow Inc   17.46 %

Date modified: 2026-09-26T07:16:16+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.